ADNP: In search for molecular mechanisms and innovative therapeutic strategies for frontotemporal degeneration

Keyphrases

• Innovative Therapies 100%
• Molecular Mechanism 100%
• Activity-dependent Neuroprotective Protein 100%
• Frontotemporal Lobar Degeneration 100%
• Tauopathy 40%
• Frontotemporal Dementia 30%
• Alzheimer's Disease 20%
• Transgenic Mice 20%
• Cognitive Impairment 20%
• Microtubules 20%
• Cerebral Cortex 20%
• Alternative Splicing 20%
• Microtubule-associated Protein 20%
• Alzheime's Disease 20%
• Cognitive Deficits 10%
• Schizophrenia 10%
• Overexpressing 10%
• Aging 10%
• Mini 10%
• Brain Activity 10%
• Disease Onset 10%
• Clinical Evaluation 10%
• Autism 10%
• Littermate 10%
• Novel Therapeutic Targets 10%
• Chromatin Remodelers 10%
• Haploinsufficiency 10%
• Cognitive Score 10%
• Functional Activity 10%
• Social Deficits 10%
• Amnestic 10%
• Brain Formation 10%
• Transcript Expression 10%
• Cellular Interactions 10%
• Progressive Supranuclear Palsy 10%
• Schizophrenic 10%
• SWItch/sucrose Non-fermentable 10%
• Mouse Activity 10%
• Mutated tau 10%
• Novel Drug Candidates 10%

Neuroscience

• Neuroprotective Agent 100%
• Tauopathy 40%
• Frontotemporal Dementia 30%
• Alzheimer's Disease 20%
• Microtubule 20%
• Cerebral Cortex 20%
• Alternative Splicing 20%
• Schizophrenia 20%
• Chromatin Assembly and Disassembly 10%
• Cell Interaction 10%
• Haploinsufficiency 10%
• Microtubule Associated Protein 10%
• Sucrose 10%
• Progressive Supranuclear Palsy 10%
• Microtubule Protein 10%
• Autism 10%